| Authors: |
Campling J; Medical Affairs, Pfizer Ltd, Walton Oaks, UK., Vyse A; Medical Affairs, Pfizer Ltd, Walton Oaks, UK., Liu HH; Real-World Evidence, OPEN Health, London, UK., Wright H; Medical Affairs, Pfizer Ltd, Walton Oaks, UK., Slack M; School of Medicine & Dentistry, Griffith University, Southport, Queensland, Australia., Reinert RR; Medical Affairs, Pfizer Inc, Pfizer, Paris, France., Drayson M; Institute of Immunology and Immunotherapy, Medical School, University of Birmingham, Edgbaston, Birmingham, UK., Richter A; Institute of Immunology and Immunotherapy, Medical School, University of Birmingham, Edgbaston, Birmingham, UK., Singh D; Division of Immunology, Immunity to Infection and Respiratory Medicine, University of Manchester, Manchester, UK., Barlow G; Hull York Medical School, University of York, York, UK., Kassianos G; Royal College of General Practitioners, London, UK.; British Global & Travel Health Association, Bath, UK., Ellsbury G; Medical Affairs, Pfizer Ltd, Walton Oaks, UK. |
